2nd Strategic Partnerships for Drug Repurposing Forum - Hyatt Regency Boston Harbor

2nd Strategic Partnerships for Drug Repurposing Forum
October 26 - 27, 2017
Hyatt Regency Boston Harbor
Boston, MA

Understand the importance of drug repurposing, repositioning and rescue through innovative strategies

Agenda – 2nd Strategic Partnerships for Drug Repurposing Forum



Day One

 Thursday, October 26, 2017

8:45AM – 9:00AM

Co-Chairpersons’ Opening Remarks


Bruce Bloom, President and Chief Science Officer, CURES WITHIN REACH
Craig Wegner, Executive Director, Boston Head, Emerging Innovations, Scientific Partnering and Alliances, ASTRAZENECA PHARMACEUTICALS

9:00AM – 9:45AM

Big Data and Drug Repositioning: Made for Each Other


Aris Persidis, President, BIOVISTA

9:45AM – 10:30AM

CASE STUDY: Clinical Validation Successes Have Now Emerged From Strategic Open Innovation Partnerships – Is This Now a Certified Path for Drug Repositioning


Craig Wegner, Executive Director, Boston Head, Emerging Innovations, Scientific Partnering and Alliances, ASTRAZENECA

10:30AM – 11:00AM

Networking Break


11:00AM – 11:45AM

PANEL: Partnerships With Sponsors, Patient Advocacy, Government and Research of Drug Developments


Brian Fisher, Vice President of Operations and Corporate Partnerships, STURGE-WEBER FOUNDATION
Bobbie Austin, Program Officer, Drug Development Partnership Programs, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NIH
Chitra Edwin, RAC Senior Vice President of Regulatory Affairs and Compliance, SPOTLIGHT INNOVATION
Sean Evans, Associate Director, Business Development and Corporate Partnerships Johns Hopkins Technology Ventures, Johns Hopkins University

12:30PM – 1:30PM

Networking Lunch


1:30PM – 2:15PM

Recycling the Recycling Model: Building Economic Incentives Into Generic Drug Repurposing


Bruce Bloom, President and Chief Science Officer, CURES WITHIN REACH

2:15PM – 3:00PM

Panel: Two Case Studies on Computational Strategies for Drug Repurposing


Moderator:
Bobbie Austin, Program Officer, Drug Development Partnership Programs, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NIH

Panelists:
David M. Aronoff, Director, Division of Infectious Diseases, Addison B. Scoville Jr. Chair in Medicine, Professor of Medicine, VANDERBILT UNIVERSITY
Bin Chen, Assistant Professor, Dept. of Pediatrics and Institute for Computational Health Sciences, UCSF

3:00PM – 3:45PM

Pharma Experiences and Challenges in Evolving New Technologies for Repurposing Drugs


Pankaj Agarwal, GSK Senior Fellow, Computational Biology, GLAXOSMITHKLINE

3:45PM – 4:15PM

Networking Break


4:15PM – 5:00PM

Phenotypic Screening and Machine Learning: A Powerful Combination for Future Drug Discovery and Repurposing


Hassan Al-Ali, Ph.D., Research Assistant Professor, UNIVERSITY OF MIAMI; Chief Scientific Officer, TRUVITECH LLC

5:00PM – 5:45PM

Integrative Technology Platform to Speed Up the Process of Drug Repurposing


Stephen Wong, Chairman and Professor, Department of Systems Medicine and Bioengineering, and Chief Research Information Officer, HOUSTON METHODIST HOSPITAL


Day Two

 Friday, October 27, 2017

8:00AM – 8:30AM

Continental Breakfast


8:30AM – 8:45AM

Co-Chairpersons’ Recap of Day One


Bruce Bloom, President and Chief Science Officer, CURES WITHIN REACH
Craig Wegner, Executive Director, Boston Head, Emerging Innovations, Scientific Partnering and Alliances, ASTRAZENECA PHARMACEUTICALS

8:45AM – 9:30AM

Predict the Safety and Efficacy of Small Molecules Using Deep Learning Techniques


Alex Aliper, President of European Operations, INSILICO MEDICINE

9:30AM – 10:15AM

Drug Repurposing for Rare Diseases at National Center of Toxicological Research


Zhichao Liu, Staff Fellow, NCTR, FDA

10:15AM – 11:00AM

A Pharma Approach to Industrializing Methodologies for Identification of Robust Drug Repurposing Candidates


Daphna Laifenfeld, Senior Director, Personalized and Predictive Medicine, TEVA

11:00AM – 11:30AM

Networking Break


11:30AM – 12:15PM

PANEL: How to Evaluate the Pricing and Value of a Repurposed Drug


Antoun Nabhan, Chief Financial Officer, ESTABLISHMENT LABS

12:15PM – 1:00PM

CASE STUDY: Engaging the Patient Community in Repurposed Drug Trials


Bernadette Siddiqi, Research Programs Officer, THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH

1:00PM – 2:00PM

Luncheon


2:00PM – 2:45PM

CASE STUDY: The Development of a New Molecule of an Old Drug in a New Orphan Disease


Raymond K. Houck, President and Chief Executive Officer, THAR PHARMACEUTICALS

2:45PM – 3:15PM

CASE STUDY: Explore Development Paths and Challenges in Drug Repurposing


Neal Farber, Chief Executive Officer, NEUROHEALING PHARMACEUTICALS

3:15PM – 3:45PM

Networking Break


3:45PM – 4:15PM

A KnowledgeBase to Aggregate and Prioritize Data on Generic Drug Repurposing for Cancer


Laura Kleiman, Executive Director, CURES WITHIN REACH FOR CANCER

4:15PM – 4:15PM

Conference Concludes



live chat software